Want to see GB:IHC full AI Analyst Report?
Top Page
Inspiration Healthcare
(LSE:IHC)
Select Model
Select Model
Rating:53Neutral
Price Target:
19.50 p
▲(5.41% Upside)
Action:Reiterated
Date:06/18/26
The score is driven primarily by improving 2026 fundamentals—especially the sharp rebound in operating and free cash flow—offset by continued net losses and prior-year volatility. Technical indicators are currently weak (bearish trend with negative MACD) despite oversold readings, and valuation is constrained by a negative P/E with no dividend yield provided.
Positive Factors
Revenue Growth
The reported revenue growth indicates expanding demand for the company’s medical technology products and services. If maintained, stronger sales can improve operating leverage, support broader customer adoption, and provide a larger base from which recurring consumables and service revenue can develop.
Negative Factors
Continuing Net Losses
Despite the operating rebound, the company still loses money after all expenses, showing that the turnaround has not yet translated into bottom-line profitability. Continued net losses can consume equity, constrain reinvestment, and make future performance more dependent on sustaining operational improvements.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue Growth
The reported revenue growth indicates expanding demand for the company’s medical technology products and services. If maintained, stronger sales can improve operating leverage, support broader customer adoption, and provide a larger base from which recurring consumables and service revenue can develop.
Read all positive factors
Inspiration Healthcare (IHC) vs. iShares MSCI United Kingdom ETF (EWC)
Market Cap
£17.04M
Dividend Yield1.56%
Average Volume (3M)34.28K
Price to Earnings (P/E)―
Beta (1Y)-0.12
Revenue Growth24.30%
EPS Growth93.53%
CountryUK
Employees194
SectorHealthcare
Sector Strength45
IndustryMedical - Devices
Share Statistics
EPS (TTM)-0.01
Shares Outstanding89,663,370
10 Day Avg. Volume67,138
30 Day Avg. Volume34,283
Financial Highlights & Ratios
PEG Ratio0.14
Price to Book (P/B)0.89
Price to Sales (P/S)0.29
P/FCF Ratio2.22
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)>-0.01
Revenue Forecast (FY)£40.33M
Inspiration Healthcare Business Overview & Revenue Model
Company Description
Inspiration Healthcare Group plc (IHC.L) is a global provider of advanced medical technology, catering to critical care, operating theatre, and home healthcare applications worldwide. The company offers a comprehensive range of products, with a st...
How the Company Makes Money
IHC makes money primarily by selling medical devices and consumables to healthcare providers. Its revenue model typically includes: (1) Product sales: income from supplying third-party medical equipment and consumables (and any owned brands/produc...
Inspiration Healthcare Financial Statement Overview
Summary
Income Statement
54
Neutral
Balance Sheet
58
Neutral
Cash Flow
66
Positive
| Breakdown | Jan 2025 | Jan 2024 | Jan 2023 | Jan 2022 | Jan 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 47.55M | 38.25M | 37.63M | 41.23M | 41.05M |
| Gross Profit | 20.07M | 16.38M | 17.89M | 17.63M | 20.25M |
| EBITDA | 2.37M | -12.44M | -2.43M | 2.76M | 6.17M |
| Net Income | -1.04M | -14.97M | -6.03M | 272.00K | 4.23M |
Balance Sheet | |||||
| Total Assets | 35.71M | 41.08M | 49.01M | 54.89M | 50.11M |
| Cash, Cash Equivalents and Short-Term Investments | 1.17M | 733.00K | 609.00K | 2.28M | 9.25M |
| Total Debt | 11.77M | 14.97M | 12.83M | 13.08M | 7.54M |
| Total Liabilities | 20.04M | 24.45M | 20.05M | 19.42M | 14.62M |
| Stockholders Equity | 15.67M | 16.64M | 28.97M | 35.47M | 35.49M |
Cash Flow | |||||
| Free Cash Flow | 6.27M | -3.52M | 380.00K | -11.86M | -436.00K |
| Operating Cash Flow | 6.88M | -1.55M | 2.01M | -3.52M | 3.54M |
| Investing Cash Flow | -2.97M | -1.74M | -2.69M | -8.34M | -3.97M |
| Financing Cash Flow | -3.47M | 3.61M | -1.19M | 4.88M | -964.00K |
Inspiration Healthcare Technical Analysis
Positive
18.50
Price Trends
18.78
Positive
22.89
Negative
20.90
Negative
Market Momentum
-0.04
Negative
55.98
Neutral
40.00
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GB:IHC, the sentiment is Positive. The current price of 18.5 is below the 20-day moving average (MA) of 18.60, below the 50-day MA of 18.78, and below the 200-day MA of 20.90, indicating a neutral trend. The MACD of -0.04 indicates Negative momentum. The RSI at 55.98 is Neutral, neither overbought nor oversold. The STOCH value of 40.00 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for GB:IHC.
Inspiration Healthcare Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | £4.43B | 48.65 | 8.40% | 2.45% | 1.94% | -43.71% | |
72 Outperform | £608.10M | 60.82 | 3.87% | 1.67% | 28.96% | 39.58% | |
68 Neutral | £197.58M | 24.94 | 23.64% | 3.45% | 13.71% | 27.65% | |
68 Neutral | £8.91B | 18.92 | 12.25% | 2.76% | 2.17% | 27.33% | |
55 Neutral | £3.96M | -4.25 | -11.04% | ― | -2.87% | 52.38% | |
53 Neutral | £17.04M | -16.38 | -6.49% | 1.56% | 24.30% | 93.53% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
* Healthcare Sector Average
GB:IHC
Inspiration Healthcare
19.00
-2.50
-11.63%
GB:AMS
Advanced Medical Solutions
281.00
74.22
35.89%
GB:CTEC
ConvaTec
228.20
-5.23
-2.24%
GB:SUN
Surgical Innovations
0.43
-0.27
-39.29%
GB:TSTL
Tristel
411.00
55.05
15.47%
GB:SN
Smith & Nephew
1,064.00
-315.85
-22.89%
Inspiration Healthcare Corporate Events
Business Operations and StrategyExecutive/Board Changes
Inspiration Healthcare grants performance-linked share options to top executives
Positive
Aug 7, 2026
Inspiration Healthcare Group has granted 2,759,141 nil-cost share options under its Long-Term Incentive Plan, including substantial awards to chief executive Raffi Stepanian and chief financial officer Alan Olby. The grants comprise both performan...
Business Operations and StrategyShareholder Meetings
Inspiration Healthcare shareholders back all AGM resolutions
Positive
Jul 23, 2026
Inspiration Healthcare Group, a specialist in neonatal intensive care devices and related medical technologies, operates from its manufacturing and technology centre in Croydon and a U.S. facility in Melbourne, Florida, supplying hospitals in over...
Business Operations and StrategyFinancial Disclosures
Inspiration Healthcare Sharpens Neonatal Focus After Strong FY26 Growth
Positive
Jul 23, 2026
Inspiration Healthcare reported that FY26 marked a shift from stabilisation to growth execution, with strategy centred on strengthening its neonatal core, expanding internationally and improving operations. The group highlighted progress in cash g...
Business Operations and StrategyShareholder Meetings
Inspiration Healthcare Drops Share Issuance and Buyback Powers After Investor Feedback
Neutral
Jul 20, 2026
Inspiration Healthcare Group plc has withdrawn two special resolutions from the agenda of its upcoming annual general meeting following feedback from a significant shareholder. The resolutions related to disapplying pre-emption rights for cash iss...
Business Operations and StrategyFinancial DisclosuresShareholder Meetings
Inspiration Healthcare Publishes 2026 Annual Report and Moves AGM Voting Online
Positive
Jun 26, 2026
Inspiration Healthcare Group has released its Annual Report and Accounts for the year ended 31 January 2026, alongside the formal notice of its upcoming Annual General Meeting, which are now available on the company’s website and being maile...
Business Operations and StrategyFinancial Disclosures
Inspiration Healthcare boosts profits and cash as it refocuses on core neonatal tech
Positive
Jun 16, 2026
Inspiration Healthcare reported a strong FY26 performance, with revenue rising 24% to £47.5m, driven by a 56% surge in SLE product sales, improved gross margins and a swing to £2.8m in adjusted EBITDA. Tighter working capital management ...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.